COVID-19 Briefing Series: Impact of COVID-19 on Healthcare Market Research

The COVID-19 pandemic continues to have an unprecedented impact on our lives and is disrupting businesses as it spreads worldwide. The social distancing measures that are critically important to address the pandemic present new challenges with patient recruitment for clinical trials, market research, and drug launches.

In this time of uncertainty, Trinity is assessing the impact on market research services including the ability of healthcare providers to participate in research.

In its latest brief, “Impact of COVID-19 on Healthcare Market Research,” Trinity provides insights for life science companies to help them navigate these uncertain times.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit

For more information:

Elizabeth Marshall
Trinity Life Sciences

See all Thought Leadership posts